Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”
Therapeutic Advances in Psychopharmacology · 2026-05 · 16
DOI: 10.1177/20451253261452482 ↗Kurz gefasst
Korrektur in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 19.05.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Depression
Abstract (Originalsprache)
[This corrects the article DOI: 10.1177/20451253261437597.].
Zitieren
APA
(2026). Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261452482
Vancouver
Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261452482
BibTeX
@article{euvimed2026,
title = {Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2026},
volume = {16},
doi = {10.1177/20451253261452482}
}
EUVIMED